Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease

6 Dec 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35572351
DOI: 10.1038/s43587-021-00138-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s diseasePMID 35572351Read ↗

Drug repurposing of metformin for Alzheimer’s disease: Combining causal inference in medical records data and systems pharmacology for biomarker identificationSemantic proximity Read ↗

Harnessing network pharmacology and in silico drug discovery to uncover new targets and therapeutics for Alzheimer's diseaseSemantic proximity Read ↗

Alz-QNet: A quantum regression network for studying Alzheimer’s gene interactionsSemantic proximity Read ↗

Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records.Semantic proximity Read ↗

The Use of Different Types of Networks, Alone and in Combination, for Drug Target IdentificationSemantic proximity Read ↗

Pharmacogenomics of Alzheimer’s and Parkinson’s diseasesSemantic proximity Read ↗

Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer’s diseaseSemantic proximity Read ↗

Commentary: Endophenotypes as Disease Modifiers: Decoding the Biology of Alzheimer's by Genome-wide Association Studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.